Bionano Genomics, Inc.

NASDAQ:BNGO

0.195 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 6.0737.7718.76910.7219.3188.6627.4158.2157.2216.675.6966.3024.6553.8563.1683.992.1961.1821.1362.7893.3132.1751.8534.0142.8293.391.7682.8452.7432.1961.721
Cost of Revenue 14.5195.1865.9458.2836.5696.3545.3456.415.4125.1994.8356.0633.5012.4172.1252.8111.460.6030.8561.6912.3751.5551.1472.9883.0681.8130.8411.4961.691.6391.205
Gross Profit -8.4462.5852.8242.4382.7492.3082.071.8051.8091.4710.8610.2391.1541.4391.0431.1780.7360.5790.281.0980.9380.6190.7061.025-0.241.5770.9271.3491.0530.5570.515
Gross Profit Ratio -1.3910.3330.3220.2270.2950.2660.2790.220.2510.2210.1510.0380.2480.3730.3290.2950.3350.490.2460.3940.2830.2850.3810.255-0.0850.4650.5240.4740.3840.2540.3
Reseach & Development Expenses 4.7176.8319.77911.70113.78514.6113.93714.01112.74211.76710.5279.2156.5054.0862.6782.8772.3042.4012.6742.3992.1742.4082.12.5212.5052.0992.3672.4572.9673.3943.19
General & Administrative Expenses 0000000000000009.4288.6595.6137.3685.864.4495.0564.7914.6033.2243.492.89503.11703.513
Selling & Marketing Expenses 0000000000000000.001000000000000000
SG&A 9.46411.55720.17610.77124.89626.93625.97625.32121.21621.78320.27719.80715.32713.8299.5289.4298.6595.6137.3685.864.4495.0564.7914.6033.2243.492.8953.5263.1173.9233.513
Other Expenses 21.2741.215-1.239-15.2650.026-0.2560.117-0.040.005-0.156-0.0330.037-0.067-0.015-0.015-0.6030.054-0.0730.018-0.74-0.131-0.25-0.468-0.037-0.076-0.062-0.159-0.164-0.068-0.036-0.021
Operating Expenses 35.45519.60329.95522.47238.68141.54639.91339.33233.95833.5530.80429.02221.83217.91512.20612.30610.9638.01410.0428.2596.6237.4646.8917.1245.7295.5895.2625.9846.0847.3186.703
Operating Income -43.901-17.018-27.131-20.034-113.212-39.238-37.843-37.527-32.149-32.079-29.943-28.783-20.678-16.476-11.163-11.128-10.227-7.435-9.762-7.16-5.685-6.844-6.185-6.099-5.969-4.012-4.335-5.239-5.031-6.76-6.188
Operating Income Ratio -7.229-2.19-3.094-1.869-12.15-4.53-5.104-4.568-4.452-4.809-5.257-4.567-4.442-4.273-3.524-2.789-4.657-6.29-8.593-2.567-1.716-3.147-3.338-1.519-2.11-1.184-2.452-1.842-1.834-3.078-3.596
Total Other Income Expenses Net -0.3210.82-0.317-18.9740.6850.3590.7450.6550.368-0.03800.067-0.04-2.3011.222-0.615-0.535-0.634-0.743-0.733-0.709-0.816-1.662-0.3041.040.7060.492-0.68-0.0590.0950.516
Income Before Tax -44.222-16.198-31.44-43.927-112.527-38.879-37.098-36.872-31.781-32.117-29.943-28.716-20.718-18.777-9.941-11.731-10.762-8.069-10.505-7.901-6.394-7.66-7.847-6.402-4.929-3.306-3.844-5.919-5.09-6.665-5.672
Income Before Tax Ratio -7.282-2.084-3.585-4.097-12.076-4.488-5.003-4.488-4.401-4.815-5.257-4.557-4.451-4.87-3.138-2.94-4.901-6.827-9.247-2.833-1.93-3.522-4.235-1.595-1.743-0.975-2.173-2.08-1.856-3.035-3.296
Income Tax Expense 0.0240.026-0.018-0.0360.0390.0330.0261.8050.0280.0410.009-5.7670.0350.0090.006-0.0110.030.0050.0050.0080.0040.0040.0040.009-0.0030.0060.0040.001-0.0050.0090.013
Net Income -44.246-16.224-31.422-43.891-112.566-38.912-37.124-38.677-31.809-32.158-29.952-22.949-20.753-18.786-9.947-11.731-10.792-8.074-10.51-7.901-6.398-7.665-7.852-6.411-4.926-3.311-3.847-5.92-5.085-6.674-5.686
Net Income Ratio -7.286-2.088-3.583-4.094-12.08-4.492-5.007-4.708-4.405-4.821-5.258-3.642-4.458-4.872-3.14-2.94-4.914-6.831-9.252-2.833-1.931-3.525-4.238-1.597-1.741-0.977-2.176-2.081-1.854-3.039-3.304
EPS -0.52-0.24-0.6-0.96-3.22-1.24-1.23-1.3-1.1-1.13-1.05-0.81-0.74-0.7-0.38-1.13-0.81-0.89-2.95-2.83-5.87-7.06-7.69-6.38-6.33-9.84-7.36-1.13-9.73-1.28-10.88
EPS Diluted -0.52-0.24-0.6-0.96-3.22-1.24-1.23-1.3-1.1-1.13-1.05-0.81-0.74-0.67-0.38-1.13-0.81-0.89-2.95-2.83-5.87-7.06-7.69-6.37-6.33-9.84-7.36-1.13-9.73-1.28-10.88
EBITDA -43.901-12.713-28.26-35.433-108.831-35.601-33.719-33.936-29.282-29.74-27.627-26.029-20.192-18.051-8.955-10.567-9.909-7.213-9.448-6.71-5.537-6.844-7.305-5.985-4.133-2.511-3.15-4.096-4.704-6.15-5.177
EBITDA Ratio -7.229-1.636-2.745-1.533-3.381-4.093-4.993-4.479-4.054-4.451-4.85-4.524-4.329-4.143-3.387-2.789-4.488-6.102-8.317-2.567-1.671-3.139-3.445-1.529-1.999-1.088-2.32-1.497-1.771-2.926-3.403